Share Price and Basic Stock Data
Last Updated: February 27, 2026, 3:22 pm
| PEG Ratio | 0.00 |
|---|
📊 Last updated
1d ago
Feb 26, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Balgopal Commercial Ltd operates in the trading and distribution sector, with a market capitalization of ₹332 Cr and a current share price of ₹174. The company’s revenue trends have shown significant fluctuations over the past quarters. In the fiscal year ending March 2023, Balgopal reported total sales of ₹8.19 Cr, a modest increase from ₹8.00 Cr in the previous year. However, the revenue for the first half of the fiscal year 2024 has shown a notable improvement, with sales rising to ₹17.05 Cr, driven by a substantial surge in quarterly sales, particularly in September 2023, where sales soared to ₹6.03 Cr, followed by ₹8.92 Cr in December 2023. This impressive growth in sales indicates a potential recovery in business activity after a challenging period marked by lower sales figures in prior quarters. The overall trend suggests that the company is regaining its footing in the market, aligning with the broader recovery patterns observed in the trading sector post-pandemic.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Balgopal Commercial Ltd | 340 Cr. | 179 | 273/107 | 30.6 | 0.00 % | 14.8 % | 12.6 % | 10.0 | |
| Candour Techtex Ltd | 373 Cr. | 153 | 165/68.0 | 22.1 | 0.00 % | 6.53 % | 2.18 % | 10.0 | |
| Beekay Niryat Ltd | 287 Cr. | 263 | 277/124 | 82.4 | 60.6 | 0.09 % | 7.17 % | 6.44 % | 10.0 |
| Sakuma Exports Ltd | 285 Cr. | 1.83 | 3.82/1.60 | 38.1 | 4.62 | 0.00 % | 2.79 % | 1.91 % | 1.00 |
| Shankara Building Products Ltd | 263 Cr. | 108 | 295/98.2 | 10.5 | 181 | 2.77 % | 16.8 % | 9.29 % | 10.0 |
| Industry Average | 9,486.86 Cr | 150.44 | 102.90 | 119.07 | 0.43% | 15.22% | 8.81% | 7.62 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.93 | 2.01 | 1.08 | 1.00 | 6.03 | 8.92 | 1.09 | 0.05 | 0.33 | 0.18 | 0.00 | 0.00 | 0.00 |
| Expenses | 3.81 | 2.00 | 1.17 | 0.97 | 4.62 | 7.69 | 1.39 | 0.22 | 0.24 | 0.45 | 0.36 | 0.30 | 0.12 |
| Operating Profit | 0.12 | 0.01 | -0.09 | 0.03 | 1.41 | 1.23 | -0.30 | -0.17 | 0.09 | -0.27 | -0.36 | -0.30 | -0.12 |
| OPM % | 3.05% | 0.50% | -8.33% | 3.00% | 23.38% | 13.79% | -27.52% | -340.00% | 27.27% | -150.00% | |||
| Other Income | 1.84 | 1.87 | -3.81 | 2.07 | 2.74 | 2.74 | 4.23 | 4.69 | 7.93 | 0.17 | -4.65 | 2.34 | 0.03 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 1.96 | 1.88 | -3.90 | 2.10 | 4.15 | 3.97 | 3.93 | 4.52 | 8.02 | -0.10 | -5.01 | 2.04 | -0.18 |
| Tax % | 10.71% | 5.85% | -3.08% | 23.33% | 0.72% | 6.80% | 5.09% | 14.16% | 11.35% | 170.00% | -12.57% | 17.65% | -11.11% |
| Net Profit | 1.75 | 1.77 | -3.78 | 1.61 | 4.11 | 3.70 | 3.74 | 3.88 | 7.10 | -0.27 | -4.38 | 1.68 | -0.16 |
| EPS in Rs | 1.06 | 1.07 | -2.29 | 0.98 | 2.49 | 2.24 | 2.27 | 2.35 | 4.30 | -0.16 | -2.30 | 0.88 | -0.08 |
Last Updated: December 27, 2025, 10:05 pm
Below is a detailed analysis of the quarterly data for Balgopal Commercial Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.30 Cr. (Jun 2025) to 0.12 Cr., marking a decrease of 0.18 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.12 Cr.. The value appears strong and on an upward trend. It has increased from -0.30 Cr. (Jun 2025) to -0.12 Cr., marking an increase of 0.18 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Other Income, as of Sep 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 2.34 Cr. (Jun 2025) to 0.03 Cr., marking a decrease of 2.31 Cr..
- For Interest, as of Sep 2025, the value is 0.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Jun 2025) to 0.09 Cr., marking an increase of 0.09 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 2.04 Cr. (Jun 2025) to -0.18 Cr., marking a decrease of 2.22 Cr..
- For Tax %, as of Sep 2025, the value is -11.11%. The value appears to be improving (decreasing) as expected. It has decreased from 17.65% (Jun 2025) to -11.11%, marking a decrease of 28.76%.
- For Net Profit, as of Sep 2025, the value is -0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 1.68 Cr. (Jun 2025) to -0.16 Cr., marking a decrease of 1.84 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.08. The value appears to be declining and may need further review. It has decreased from 0.88 (Jun 2025) to -0.08, marking a decrease of 0.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 27, 2026, 12:05 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.81 | 3.81 | 2.60 | 4.57 | 14.80 | 16.40 | 9.61 | 5.36 | 8.00 | 8.19 | 17.05 | 0.56 | 0.02 |
| Expenses | 0.80 | 4.13 | 3.00 | 5.22 | 15.97 | 19.79 | 18.16 | 6.13 | 8.55 | 8.00 | 14.69 | 1.27 | 1.28 |
| Operating Profit | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -0.77 | -0.55 | 0.19 | 2.36 | -0.71 | -1.26 |
| OPM % | 1.23% | -8.40% | -15.38% | -14.22% | -7.91% | -20.67% | -88.97% | -14.37% | -6.88% | 2.32% | 13.84% | -126.79% | -6,300.00% |
| Other Income | 0.00 | 0.40 | 0.45 | 0.70 | 0.82 | 1.29 | 1.57 | 7.52 | 0.92 | -0.05 | 11.79 | 8.14 | -1.44 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.09 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.01 | 0.08 | 0.05 | 0.05 | -0.35 | -2.10 | -6.98 | 6.75 | 0.37 | 0.04 | 14.15 | 7.43 | -2.79 |
| Tax % | 0.00% | 25.00% | 40.00% | 20.00% | -8.57% | 6.19% | -8.17% | 14.52% | 18.92% | -350.00% | 7.00% | 14.67% | |
| Net Profit | 0.00 | 0.06 | 0.03 | 0.05 | -0.32 | -2.24 | -6.42 | 5.77 | 0.30 | 0.17 | 13.17 | 6.34 | -2.27 |
| EPS in Rs | 0.00 | 0.04 | 0.02 | 0.03 | -0.19 | -1.36 | -3.89 | 3.49 | 0.18 | 0.10 | 7.98 | 3.34 | -1.19 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 66.67% | -740.00% | -600.00% | -186.61% | 189.88% | -94.80% | -43.33% | 7647.06% | -51.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 116.67% | -806.67% | 140.00% | 413.39% | 376.48% | -284.68% | 51.47% | 7690.39% | -7698.92% |
Balgopal Commercial Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -17% |
| 5 Years: | -43% |
| 3 Years: | -59% |
| TTM: | -97% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 59% |
| 5 Years: | 24% |
| 3 Years: | 185% |
| TTM: | -73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 137% |
| 1 Year: | 165% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 2:36 pm
Balance Sheet
Last Updated: December 10, 2025, 3:54 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.24 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 19.01 | 19.01 |
| Reserves | 17.75 | 1.54 | 1.57 | 1.61 | 1.29 | -0.95 | -7.36 | -1.59 | -1.27 | -1.10 | 12.07 | 37.65 | 39.17 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 6.88 |
| Other Liabilities | 0.00 | 4.24 | 0.02 | 0.46 | 0.47 | 0.11 | 0.39 | 1.35 | 3.53 | 2.23 | 6.17 | 7.81 | 6.86 |
| Total Liabilities | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 | 71.92 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 7.42 | 2.40 | 5.79 | 7.42 | 3.60 | 4.28 | 4.48 | 11.44 | 16.89 | 7.28 | 21.09 | 40.03 | 35.66 |
| Other Assets | 10.57 | 19.89 | 12.31 | 11.16 | 14.67 | 11.39 | 5.06 | 5.08 | 1.88 | 10.36 | 13.66 | 24.44 | 36.26 |
| Total Assets | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 | 71.92 |
Below is a detailed analysis of the balance sheet data for Balgopal Commercial Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 19.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.01 Cr..
- For Reserves, as of Sep 2025, the value is 39.17 Cr.. The value appears strong and on an upward trend. It has increased from 37.65 Cr. (Mar 2025) to 39.17 Cr., marking an increase of 1.52 Cr..
- For Borrowings, as of Sep 2025, the value is 6.88 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 6.88 Cr., marking an increase of 6.88 Cr..
- For Other Liabilities, as of Sep 2025, the value is 6.86 Cr.. The value appears to be improving (decreasing). It has decreased from 7.81 Cr. (Mar 2025) to 6.86 Cr., marking a decrease of 0.95 Cr..
- For Total Liabilities, as of Sep 2025, the value is 71.92 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 64.47 Cr. (Mar 2025) to 71.92 Cr., marking an increase of 7.45 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 35.66 Cr.. The value appears to be declining and may need further review. It has decreased from 40.03 Cr. (Mar 2025) to 35.66 Cr., marking a decrease of 4.37 Cr..
- For Other Assets, as of Sep 2025, the value is 36.26 Cr.. The value appears strong and on an upward trend. It has increased from 24.44 Cr. (Mar 2025) to 36.26 Cr., marking an increase of 11.82 Cr..
- For Total Assets, as of Sep 2025, the value is 71.92 Cr.. The value appears strong and on an upward trend. It has increased from 64.47 Cr. (Mar 2025) to 71.92 Cr., marking an increase of 7.45 Cr..
Notably, the Reserves (39.17 Cr.) exceed the Borrowings (6.88 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -1.02 | -0.55 | 0.19 | 2.36 | -0.71 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365.00 | 233.75 | 4.21 | 112.61 | 195.57 | 107.94 | 109.01 | 121.89 | 15.06 | 25.85 | 0.00 | 0.00 |
| Inventory Days | 2,737.50 | 780.21 | 1,056.29 | 411.08 | 114.63 | 61.12 | 0.00 | 47.74 | 68.23 | 280.44 | 14.79 | |
| Days Payable | 0.00 | 407.49 | 0.00 | 32.92 | 11.15 | 0.00 | 46.27 | 97.68 | 88.38 | 0.00 | ||
| Cash Conversion Cycle | 3,102.50 | 606.48 | 1,060.50 | 490.78 | 299.04 | 169.06 | 109.01 | 123.36 | -14.39 | 217.90 | 14.79 | 0.00 |
| Working Capital Days | 4,763.02 | 1,491.61 | 1,715.50 | 852.20 | 349.22 | 251.94 | 158.76 | 264.90 | -53.84 | 365.45 | 160.34 | 6,537.41 |
| ROCE % | 0.06% | 0.44% | 0.28% | 0.28% | -1.11% | -12.59% | -56.50% | 55.51% | -1.97% | -16.64% | 17.50% | 14.81% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 15 | Mar 14 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.70 | 7.97 | 0.04 | 0.12 |
| Diluted EPS (Rs.) | 3.52 | 7.97 | 0.04 | 0.12 |
| Cash EPS (Rs.) | 3.31 | 7.97 | 0.03 | 0.15 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.77 | 17.31 | 10.99 | 757.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.77 | 17.31 | 10.99 | 757.55 |
| Revenue From Operations / Share (Rs.) | 0.29 | 10.32 | 2.56 | 33.95 |
| PBDIT / Share (Rs.) | 3.88 | 8.57 | 0.04 | 0.22 |
| PBIT / Share (Rs.) | 3.88 | 8.57 | 0.04 | 0.19 |
| PBT / Share (Rs.) | 3.88 | 8.57 | 0.04 | 0.19 |
| Net Profit / Share (Rs.) | 3.31 | 7.97 | 0.03 | 0.11 |
| NP After MI And SOA / Share (Rs.) | 3.31 | 7.97 | 0.03 | 0.11 |
| PBDIT Margin (%) | 1320.52 | 82.98 | 1.84 | 0.66 |
| PBIT Margin (%) | 1320.52 | 82.98 | 1.84 | 0.56 |
| PBT Margin (%) | 1320.52 | 82.98 | 1.84 | 0.56 |
| Net Profit Margin (%) | 1125.62 | 77.23 | 1.39 | 0.34 |
| NP After MI And SOA Margin (%) | 1125.62 | 77.23 | 1.39 | 0.34 |
| Return on Networth / Equity (%) | 11.12 | 46.07 | 0.32 | 0.01 |
| Return on Capital Employeed (%) | 12.50 | 49.40 | 0.42 | 0.02 |
| Return On Assets (%) | 9.49 | 37.89 | 0.26 | 0.01 |
| Long Term Debt / Equity (X) | 0.02 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.01 | 0.00 | 0.20 | 0.00 |
| Current Ratio (X) | 3.40 | 2.23 | 4.69 | 3112.46 |
| Quick Ratio (X) | 1.66 | 2.14 | 2.79 | 1349.68 |
| Inventory Turnover Ratio (X) | 0.08 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 308.25 | 54.98 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 551.29 | 3.22 | 0.00 | 0.00 |
| EV / EBITDA (X) | 41.75 | 3.89 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 554.85 | 3.23 | 0.00 | 0.00 |
| Price / BV (X) | 5.48 | 1.93 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 555.10 | 3.23 | 0.00 | 0.00 |
| EarningsYield | 0.02 | 0.23 | 0.00 | 0.00 |
After reviewing the key financial ratios for Balgopal Commercial Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 5. It has decreased from 7.97 (Mar 24) to 3.70, marking a decrease of 4.27.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 5. It has decreased from 7.97 (Mar 24) to 3.52, marking a decrease of 4.45.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has decreased from 7.97 (Mar 24) to 3.31, marking a decrease of 4.66.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 17.31 (Mar 24) to 29.77, marking an increase of 12.46.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 17.31 (Mar 24) to 29.77, marking an increase of 12.46.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.29. It has decreased from 10.32 (Mar 24) to 0.29, marking a decrease of 10.03.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has decreased from 8.57 (Mar 24) to 3.88, marking a decrease of 4.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has decreased from 8.57 (Mar 24) to 3.88, marking a decrease of 4.69.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has decreased from 8.57 (Mar 24) to 3.88, marking a decrease of 4.69.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has decreased from 7.97 (Mar 24) to 3.31, marking a decrease of 4.66.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has decreased from 7.97 (Mar 24) to 3.31, marking a decrease of 4.66.
- For PBDIT Margin (%), as of Mar 25, the value is 1,320.52. This value is within the healthy range. It has increased from 82.98 (Mar 24) to 1,320.52, marking an increase of 1,237.54.
- For PBIT Margin (%), as of Mar 25, the value is 1,320.52. This value exceeds the healthy maximum of 20. It has increased from 82.98 (Mar 24) to 1,320.52, marking an increase of 1,237.54.
- For PBT Margin (%), as of Mar 25, the value is 1,320.52. This value is within the healthy range. It has increased from 82.98 (Mar 24) to 1,320.52, marking an increase of 1,237.54.
- For Net Profit Margin (%), as of Mar 25, the value is 1,125.62. This value exceeds the healthy maximum of 10. It has increased from 77.23 (Mar 24) to 1,125.62, marking an increase of 1,048.39.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1,125.62. This value exceeds the healthy maximum of 20. It has increased from 77.23 (Mar 24) to 1,125.62, marking an increase of 1,048.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.12. This value is below the healthy minimum of 15. It has decreased from 46.07 (Mar 24) to 11.12, marking a decrease of 34.95.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.50. This value is within the healthy range. It has decreased from 49.40 (Mar 24) to 12.50, marking a decrease of 36.90.
- For Return On Assets (%), as of Mar 25, the value is 9.49. This value is within the healthy range. It has decreased from 37.89 (Mar 24) to 9.49, marking a decrease of 28.40.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 3.40. This value exceeds the healthy maximum of 3. It has increased from 2.23 (Mar 24) to 3.40, marking an increase of 1.17.
- For Quick Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 2.14 (Mar 24) to 1.66, marking a decrease of 0.48.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.08, marking an increase of 0.08.
- For Enterprise Value (Cr.), as of Mar 25, the value is 308.25. It has increased from 54.98 (Mar 24) to 308.25, marking an increase of 253.27.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 551.29. This value exceeds the healthy maximum of 3. It has increased from 3.22 (Mar 24) to 551.29, marking an increase of 548.07.
- For EV / EBITDA (X), as of Mar 25, the value is 41.75. This value exceeds the healthy maximum of 15. It has increased from 3.89 (Mar 24) to 41.75, marking an increase of 37.86.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 554.85. This value exceeds the healthy maximum of 3. It has increased from 3.23 (Mar 24) to 554.85, marking an increase of 551.62.
- For Price / BV (X), as of Mar 25, the value is 5.48. This value exceeds the healthy maximum of 3. It has increased from 1.93 (Mar 24) to 5.48, marking an increase of 3.55.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 555.10. This value exceeds the healthy maximum of 3. It has increased from 3.23 (Mar 24) to 555.10, marking an increase of 551.87.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.23 (Mar 24) to 0.02, marking a decrease of 0.21.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balgopal Commercial Ltd:
- Net Profit Margin: 1125.62%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.5% (Industry Average ROCE: 15.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.12% (Industry Average ROE: 8.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 102.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1125.62%
About the Company - Qualitative Analysis
Balgopal Commercial Ltd. is a Public Limited Listed company incorporated on 20/08/1982 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51109MH1982PLC368610 and registration number is 035193. Currently Company is involved in the business activities of Wholesale of other clothing items. Company's Total Operating Revenue is Rs. 0.56 Cr. and Equity Capital is Rs. 19.01 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 901, 9th Floor, Crescent Royale, CTS No. 720/42- 46, Mumbai Maharashtra 400053 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vijay Laltaprasad Yadav | Managing Director |
| Mrs. Shrena Kalpesh Shah | Ind. Non-Executive Director |
| Ms. Shailesh Becharbhai Patel | Ind. Non-Executive Director |
| Mr. Navaneet Lal Damani | Non Executive Director |
FAQ
What is the intrinsic value of Balgopal Commercial Ltd?
Balgopal Commercial Ltd's intrinsic value (as of 28 February 2026) is ₹39.71 which is 77.82% lower the current market price of ₹179.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹340 Cr. market cap, FY2025-2026 high/low of ₹273/107, reserves of ₹39.17 Cr, and liabilities of ₹71.92 Cr.
What is the Market Cap of Balgopal Commercial Ltd?
The Market Cap of Balgopal Commercial Ltd is 340 Cr..
What is the current Stock Price of Balgopal Commercial Ltd as on 28 February 2026?
The current stock price of Balgopal Commercial Ltd as on 28 February 2026 is ₹179.
What is the High / Low of Balgopal Commercial Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balgopal Commercial Ltd stocks is ₹273/107.
What is the Stock P/E of Balgopal Commercial Ltd?
The Stock P/E of Balgopal Commercial Ltd is .
What is the Book Value of Balgopal Commercial Ltd?
The Book Value of Balgopal Commercial Ltd is 30.6.
What is the Dividend Yield of Balgopal Commercial Ltd?
The Dividend Yield of Balgopal Commercial Ltd is 0.00 %.
What is the ROCE of Balgopal Commercial Ltd?
The ROCE of Balgopal Commercial Ltd is 14.8 %.
What is the ROE of Balgopal Commercial Ltd?
The ROE of Balgopal Commercial Ltd is 12.6 %.
What is the Face Value of Balgopal Commercial Ltd?
The Face Value of Balgopal Commercial Ltd is 10.0.